CHCHD3 (Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 3) is a mitochondrial protein extensively studied for its essential role in maintaining mitochondrial cristae structure and cellular respiration. It is highly expressed in energy-demanding tissues, particularly brain, heart, and skeletal muscle, where mitochondrial function is critical for cellular survival[-@crista2011]. CHCHD3 is a member of the MICOS (Mitochondrial Contact Site and Cristae Organization System) complex, which is essential for proper cristae architecture and mitochondrial dynamics.
Structure
CHCHD3 is a ~450 amino acid protein with several distinctive structural features:
CHCHD3 (Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 3) is a mitochondrial protein extensively studied for its essential role in maintaining mitochondrial cristae structure and cellular respiration. It is highly expressed in energy-demanding tissues, particularly brain, heart, and skeletal muscle, where mitochondrial function is critical for cellular survival[-@crista2011]. CHCHD3 is a member of the MICOS (Mitochondrial Contact Site and Cristae Organization System) complex, which is essential for proper cristae architecture and mitochondrial dynamics.
Structure
CHCHD3 is a ~450 amino acid protein with several distinctive structural features:
Coiled-coil domains: Two alpha-helical coiled-coil regions that mediate protein-protein interactions
CHCH (Coiled-Coil-Helix-Coiled-Coil-Helix) motif: The signature domain of twin CX9C protein family, involved in dimerization
Twin CX9C motif: Conserved cysteine-rich sequences that coordinate zinc ions and enable protein interactions
N-terminal mitochondrial targeting sequence (MTS): A cleavable signal peptide that directs import via TOM/TIM translocases
C-terminal inner membrane anchor: Facilitates localization to the mitochondrial inner membrane
The protein localizes to the mitochondrial inner membrane and cristae, where it interacts with other MICOS components including MICOS60 (MINO1) and MICOS10[--@micos2020].
Normal Function
CHCHD3 performs several essential mitochondrial functions:
Mitochondrial Cristae Organization
CHCHD3 is a core component of the MICOS complex, which maintains cristae structure and curvature:
Cristae junctions: Form and maintain contact sites between cristae and inner membrane
Cristae spacing: Regulates the distance and architecture of cristae folds
ATP synthase interaction: Coordinates with ATP synthase dimerization for optimal ATP production[-@s2008]
mtDNA Maintenance
CHCHD3 interacts with mitochondrial nucleoids and participates in mitochondrial DNA maintenance:
Association with TFAM and POLG for replication
Spatial coordination of mtDNA with cristae membranes
Regulation of mtDNA transcription
Respiratory Chain Function
CHCHD3 supports assembly and function of respiratory chain complexes:
Complex I (NADH dehydrogenase) assembly and stability
Complex IV (Cytochrome c oxidase) integration
Supercomplex formation for efficient electron transport
Cellular Energy Metabolism
By maintaining proper cristae architecture, CHCHD3 ensures:
Optimal oxidative phosphorylation efficiency
ATP production through chemiosmosis
Proper redox potential maintenance
Mitochondrial Dynamics
CHCHD3 regulates mitochondrial fusion and fission:
Coordination with OPA1 for inner membrane fusion
Interaction with mitofusins (MFN1/2) for outer membrane fusion
Regulation of mitochondrial morphology[-@c2016]
PKA Phosphorylation
CHCHD3 is regulated by cAMP-dependent protein kinase (PKA):
Phosphorylation modulates its cristae-organizing function
Links mitochondrial function to cellular signaling pathways[-@pka2007]
Role in Neurodegeneration
Parkinson's Disease
CHCHD3 loss-of-function contributes to PD pathogenesis through:
Mitochondrial dysfunction: Impaired respiratory chain function in dopaminergic neurons
Complex I deficiency: Reduced activity of complex I in substantia nigra
PINK1/Parkin pathway: Interaction with mitophagy regulators
Synaptic mitochondrial loss: Reduced synaptic mitochondria in nigrostriatal terminals[-@m2017]
Alzheimer's Disease
CHCHD3 is implicated in AD through:
Mitochondrial dysfunction: A core feature of AD pathophysiology
[@K Li et al., CHCHD3 and mitochondrial function, J Mol Neurosci 2015 (2015)](https://pubmed.ncbi.nlm.nih.gov/25821151/)
[@S Merkwirth et al., Mitochondrial cristae organization, Cell 2008 (2008)](https://pubmed.ncbi.nlm.nih.gov/19070574/)
[@C Liu et al., CHCHD3 in mitochondrial dynamics, Biochim Biophys Acta 2016 (2016)](https://pubmed.ncbi.nlm.nih.gov/26850653/)
[@M Liu et al., CHCHD3 in Parkinson's disease, Mol Neurodegener 2017 (2017)](https://pubmed.ncbi.nlm.nih.gov/28506244/)
[@X Wang et al., Mitochondrial dysfunction in Alzheimer's, Nat Rev Neurosci 2019 (2019)](https://pubmed.ncbi.nlm.nih.gov/30651646/)
[@P Pasinelli et al., Mitochondria in ALS, Nat Rev Neurosci 2020 (2020)](https://pubmed.ncbi.nlm.nih.gov/32839563/)
[@MF Moreira et al., Mitochondrial therapeutics, Pharmaceuticals 2021 (2021)](https://pubmed.ncbi.nlm.nih.gov/33808475/)
[@D Van et al., ChChd3, an inner mitochondrial membrane protein, is essential for maintaining crista integrity and mitochondrial function, J Cell Biol 2011 (2011)](https://pubmed.ncbi.nlm.nih.gov/21081504/)
[@T Ohba et al., Targeting and import mechanism of coiled-coil helix coiled-coil helix domain-containing protein 3 (ChChd3) into the mitochondrial intermembrane space, J Biol Chem 2012 (2012)](https://pubmed.ncbi.nlm.nih.gov/23019327/)
[@J Cao et al., Identification of ChChd3 as a novel substrate of the cAMP-dependent protein kinase (PKA), Cell Signal 2007 (2007)](https://pubmed.ncbi.nlm.nih.gov/17242405/)
[@R Zeiger et al., The MICOS complex and its role in mitochondrial cristae architecture, Front Cell Dev Biol 2020 (2020)](https://pubmed.ncbi.nlm.nih.gov/32852441/)